Hesperidin for Health & Longevity - Quick Reference Sheet

Hesperidin for Health & Longevity

Created on 07/13/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Hesperidin is a citrus flavonoid the body activates with gut bacteria before it works as an antioxidant and mild blood-vessel relaxant. Its clearest use is easing leg heaviness, swelling, and hemorrhoid symptoms. Heart and metabolic benefits are modest and mixed, mainly in people with raised risk. It is inexpensive and very well tolerated. (Full Review)

Protocol

Standard Dose
500 mg/day
Up to 500 mg twice daily for cardiometabolic goals
Form
Better-absorbed hesperidin
Glucosyl or 2S-hesperidin for cardiometabolic; flavonoid fraction for venous symptoms
Timing
With largest meal
Morning dosing; split higher daily doses AM/PM
Time to effect
Venous & Hemorrhoid Symptoms
Days to weeks
Leg heaviness, swelling, and hemorrhoid relief
Cardiometabolic Changes
8–12 weeks
Cholesterol, blood pressure, and inflammation
Stronger Effects
Beyond 12 weeks
Subgroup analyses show larger effects with longer use

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Bleeding disorders or full-dose anticoagulation
  • Scheduled surgery (stop 2 weeks prior)
  • Very low baseline blood pressure
Key Interactions
  • Anticoagulants and antiplatelets (warfarin, clopidogrel, aspirin)
  • Blood-pressure-lowering drugs (calcium-channel blockers, ACE inhibitors)
  • NSAIDs and antacids
  • CYP3A4/CYP2C9 substrates (simvastatin, cyclosporine)
  • Blood-thinning or pressure-lowering supplements (fish oil, garlic, ginkgo, hawthorn)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal disturbances; headache and dizziness
  • Speculative: Increased bleeding tendency; additive blood-pressure lowering; pregnancy and lactation uncertainty

Monitoring

Marker Target Why
LDL cholesterol < 100 mg/dL Hesperidin's most consistent cardiometabolic target
Triglycerides < 90 mg/dL Responsive to citrus flavanones; marker of fat metabolism
Fasting blood glucose 75–90 mg/dL Tracks any glucose-lowering effect
Hemoglobin A1c < 5.3% Reflects average blood sugar over ~3 months
High-sensitivity C-reactive protein < 1.0 mg/L (ideally < 0.5) Gauges the modest anti-inflammatory effect
Blood pressure < 120/80 mmHg Detects any additive pressure-lowering

Cadence: Baseline, recheck at 8–12 weeks, then every 6–12 months if use continues

Qualitative Assessment

  • Leg heaviness, aching, or swelling (for those using it for venous symptoms)
  • Everyday energy levels
  • Exercise tolerance and recovery
  • General sense of well-being